• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed by Auna SA

    9/4/24 5:29:25 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care
    Get the next $AUNA alert in real time by email
    SC 13D 1 fp0090091-1_sc13d.htm

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13D

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

    AUNA, S.A.

     

    (Name of Issuer)

     

    Class A Ordinary Shares, nominal value US$0.01 per share

     

    (Title of Class of Securities)

     

    L0415A 103

     

    (CUSIP Number)

     

    RWC Asset Management LLP

    Attention: Fadi Freiha

    Verde, 10 Bressenden Place

    London, SW1E 5DH

    United Kingdom

    (+44 20 7227 6000)

     

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    August 29,2024

     

    (Date of Event which Requires Filing of this Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ]

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

     

      * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

    CUSIP No. L0415A 103 13D Page 2 of 4 Pages

     

    1.   NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

    RWC Asset Management LLP
    2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    [X]
    (b)    [   ]
    3.   SEC USE ONLY
     
    4.   SOURCE OF FUNDS(see instructions)
     
    OO
    5.   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)     [  ]
    6.   CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United Kingdom
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7.   SOLE VOTING POWER
     
    00,000
    8.   SHARED VOTING POWER
     
    1,521,557
    9.   SOLE DISPOSITIVE POWER
     
    00,000
    10.   SHARED DISPOSITIVE POWER
     
    1,521,557
    11.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,521,557
    12.   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
    (see instructions)    [  ]
     
    13.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     
    5.07%
    14.   TYPE OF REPORTING PERSON (see instructions)
     
    IA

     

     

    CUSIP No. L0415A 103   13D   Page 3 of 4 Pages

     

    Item 1.  Security and Issuer.

     

    Class A Ordinary Shares, nominal value US$0.01 per share (the “Ordinary Shares”), of Auna S.A

     

    The principal executive office of Auna S.A. is located at: 

    46A, Avenue J.F. Kennedy, L-1855 Luxembourg, Grand Duchy of Luxembourg 

     

    Item 2.  Identity and Background.

     

    (a)This Schedule 13D is being filed by RWC Asset Management LLP, the “Reporting Person”.

     

    (b)The address of the principal business office of the Reporting Person is Verde, 10 Bressenden Place, London, SW1E 5DH, United Kingdom.

     

    (c)The principal business of RWC Asset Management LLP is an investment adviser, providing investment advice to institutional investors.

     

    (d)During the last five years, the Reporting Persons has not been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors).

     

    (e)During the last five years, the Reporting Person was not a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

     

    (f)The Reporting Person is incorporated under the laws of the United Kingdom.

     

    Item 3.  Source or Amount of Funds or Other Consideration.

     

    The Ordinary Shares covered by this Schedule 13D were acquired by RWC Asset Management LLP as an investment adviser on behalf of institutional investors, RWC Asset Management LLP used available cash on hand to acquire the Ordinary Shares.

     

    Item 4.  Purpose of Transaction.

     

    The purpose of transaction is to invest the Ordinary Shares on behalf of institutional investors. Therefore, the reporting person may consider making strategic investment decisions described in Items 4(a) of Schedule 13D:

     

    (a) The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer;

     

    Item 5.  Interest in Securities of the Issuer.

     

    (a), (b) The following disclosure assumes there are 30,000,000 Ordinary Shares outstanding, as reported in the prospectus dated March 21, 2024 filed by the Issuer with the Securities and Exchange Commission on March 25, 2024 pursuant to the Final Prospectus. Pursuant to Rule 13d-3 under the Act, the Reporting Persons may be deemed to beneficially own 1,521,557 shares of Ordinary Shares, which constitutes approximately 5.07% of the outstanding Ordinary Shares.

     

    (c) Except as set forth in this Schedule 13D, none of the Reporting Persons nor, to the best knowledge of the Reporting Persons, without independent verification, any person named in Item 2 hereof has effected any transaction in the Ordinary Shares during the past 60 days.

     

    (d) To the best knowledge of the Reporting Persons, no person other than the Reporting Persons has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities beneficially owned by the Reporting Person identified in this Item 5.

     

    (e) Not applicable

     

    Item 6.  Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

     

    Not applicable

     

    Item 7.  Material to Be Filed as Exhibits.

     

    Not applicable

     

     

    CUSIP No. L0415A 103   13D   Page 4 of 4 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    RWC Asset Management LLP  
       
    /s/ Fadi Freiha  
    Mr. Fadi Freiha  
    Compliance Officer    
       
    9/4/2024  
    Date  
    Get the next $AUNA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AUNA

    DatePrice TargetRatingAnalyst
    5/22/2025$7.90Buy → Hold
    HSBC Securities
    4/23/2024$12.60Buy
    HSBC Securities
    4/16/2024$16.00Overweight
    JP Morgan
    4/16/2024$14.00Overweight
    Morgan Stanley
    More analyst ratings

    $AUNA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Auna Announces 1Q25 Financial Results

      Adjusted EBITDA increases 1% FXN YoY; Peru supports quarterly results, further validating its integrated business model Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the first quarter ended March 31, 2025 ("first quarter 2025" or "1Q25"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 1Q25 Consolidated Highlights Consolidated Revenue decreased 3% YoY to S/1,042 million, increasing +4% FXN Adjusted EBITDA decreased 8% YoY to S/

      5/20/25 4:15:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of its previously announced offering of an additional $62.1 million in aggregate principal amount of its 10.000% senior secured notes (the "Additional Notes") in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act. The Additional Notes will be an issuance of Auna's existing 10.000% senior secured notes due 2029 and will be issued a

      5/7/25 7:17:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Announces Proposed Offering of Additional 10.000% Senior Secured Notes Due 2029

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced that it intends to offer additional 10.000% senior secured notes (the "Additional Notes") in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act. The Additional Notes will be an issuance of Auna's existing 10.000% senior secured notes due 2029 and will be issued as additional notes under the indenture dated as of December 18, 2023 (as amended a

      5/6/25 9:12:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    SEC Filings

    See more
    • SEC Form 6-K filed by Auna SA

      6-K - AUNA S.A. (0001799207) (Filer)

      6/6/25 4:16:25 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • SEC Form 6-K filed by Auna SA

      6-K - AUNA S.A. (0001799207) (Filer)

      5/20/25 4:23:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • SEC Form EFFECT filed by Auna SA

      EFFECT - AUNA S.A. (0001799207) (Filer)

      5/8/25 12:15:17 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    Leadership Updates

    Live Leadership Updates

    See more
    • Auna Signs Exclusive Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician group practicing at Organización Para Cuidado Integral en Oncología, S.A. de C.V. known as Opción Oncología, the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna's commitment to becoming the leading oncology provider in Mexico and marks a significant step in consolidating oncology services within Auna Mexico. As part of this agreement, eight highly regarded physicians – six oncologists and two radiation oncologists – will join Auna. Toda

      3/7/25 8:00:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna appoints Teresa Gutierrez and Guadalupe Phillips to Its Board of Directors

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a leading Latin American healthcare company operating in Mexico, Peru, and Colombia, today announced the appointment of two new independent directors, Teresa Gutierrez and Guadalupe Phillips, to its Board of Directors, effective January 1, 2025. Ms. Gutierrez is responsible for Tesla in Mexico. Prior to that, she held positions at Rappi, Mattel, Nestle, McKinsey, and Procter and Gamble. She serves on the boards of several public and private companies, including Traxion, DIRI, Vetalia, and Timser. Ms. Phillips is the Chief Executive Officer of ICA, a prominent construction and infrastructure company in Mexico after a long career holding se

      12/19/24 9:01:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Appoints Executive Vice President, Strategy and Equity Capital Markets Reinforcing Its Leadership Structure

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the appointment of Laurent "Lorenzo" Massart as Executive Vice President, Strategy and Equity Capital Markets to its executive team. "We are thrilled to welcome Lorenzo to the Auna team. With over 25 years of experience in consulting and investment banking, he brings a wealth of knowledge and expertise to this newly created role. He has been a key and trusted advisor in our strategic endeavors and has worked closely with me and Auna for the last three years, playing an integral part of our journey into Mexico and on becoming a public company,"

      9/3/24 11:30:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Auna SA

      SC 13G - AUNA S.A. (0001799207) (Subject)

      11/14/24 2:22:37 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Auna SA

      SC 13G/A - AUNA S.A. (0001799207) (Subject)

      11/13/24 10:53:24 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by Auna SA

      SC 13G - AUNA S.A. (0001799207) (Subject)

      11/12/24 6:09:04 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    Financials

    Live finance-specific insights

    See more
    • Auna Announces 1Q25 Financial Results

      Adjusted EBITDA increases 1% FXN YoY; Peru supports quarterly results, further validating its integrated business model Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the first quarter ended March 31, 2025 ("first quarter 2025" or "1Q25"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 1Q25 Consolidated Highlights Consolidated Revenue decreased 3% YoY to S/1,042 million, increasing +4% FXN Adjusted EBITDA decreased 8% YoY to S/

      5/20/25 4:15:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Announces Reporting Dates for First Quarter 2025 Financial Results

      Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its First Quarter 2025 financial results. Earnings Release Tuesday, May 20, 2025 Time: After Market Close Conference Call Wednesday, May 21, 2025 Time: 8:00 a.m. ET Quiet Period Monday, April 28 through Tuesday, May 20, 2025 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexic

      4/14/25 8:30:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Announces 4Q24 and FY 2024 Financial Results

      Adjusted EBITDA increases 20.1% FXN in FY 2024 and Net Operating Cash Flows increase 15% YoY Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the fourth quarter ended December 31, 2024 ("fourth quarter 2024" or "4Q24") and full year ended 2024 ("full-year 2024" or "FY24"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 4Q24 Consolidated Highlights Consolidated Revenue increased 4% YoY to S/1,063 million, or +11% FXN Adjusted EBIT

      3/10/25 4:15:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Auna S.A. downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded Auna S.A. from Buy to Hold and set a new price target of $7.90

      5/22/25 10:32:04 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • HSBC Securities initiated coverage on Auna S.A. with a new price target

      HSBC Securities initiated coverage of Auna S.A. with a rating of Buy and set a new price target of $12.60

      4/23/24 6:12:32 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Morgan Stanley initiated coverage on Auna S.A. with a new price target

      Morgan Stanley initiated coverage of Auna S.A. with a rating of Overweight and set a new price target of $14.00

      4/16/24 7:35:01 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care